Nanoparticulate quinazoline derivative formulations

The present invention is directed to nanoparticulate quinazoline derivative compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The nanoparticulate quinazoline derivative particles of the composition have an effective average particle size of less than about 200...

Full description

Saved in:
Bibliographic Details
Main Authors Liversidge, Gary G, Jenkins, Scott
Format Patent
LanguageEnglish
Published 13.11.2012
Online AccessGet full text

Cover

Loading…